1.
von Stebut E, Reich K, Thaci D, Koenig W, Pinter A, Korber A, Rassaf T, Waisman A, Mani V, Yates D, Frueh J, Sieder C, Melzer N, Gori T. Secukinumab Reduces Endothelial Dysfunction in Subjects with Moderate-to-Severe Plaque Psoriasis Over 52 Weeks: Results of the Exploratory CARIMA Study. J of Skin [Internet]. 2018Feb.23 [cited 2024Jul.3];2(S1):S20. Available from: https://jofskin.org/index.php/skin/article/view/290